Elicio Therapeutics, Inc.
Elicio Therapeutics, Inc. (ELTX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
eltx · stock forecast · 2 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 2 Wall Street analysts in the past 3 months
Buy
2 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$17.00
Consensus
$17.00
+25.5% upside
Low
$17.00
Median: $17 · Last Close: $13.55
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $14.23 | ↑ 5.00% |
1-day model range: $14.07–$14.39. Peak: $14.39 (+5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $29 | +117.1% |
| 2028 | $47 | +244.3% |
| 2029 | $60 | +345.2% |
| 2030 | $69 | +410.4% |
| 2031 | — | +447.7% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ELTX · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-07-17 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-04-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-08-23 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-06-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-05-22 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-05-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-04-01 | Oppenheimer | Maintains | Perform→Perform |
| 2024-01-17 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Elicio Therapeutics, Inc. (ELTX) stock. Of the recent 10 rating actions, 0 were upgrades and 0 were downgrades. 2 analysts currently cover ELTX.
Analyst Recommendation Trends
ELTX analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$20M
Revenue Next Year
$0M
↓ 100.0% YoY
EPS This Year
$-1.95
EPS Next Year
$-1.76
↓ 9.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast ELTX EPS of $-1.95 for the current fiscal year, based on estimates from 1 analysts. The ELTX revenue forecast is $20M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ELTX stock forecast is supported by two independent data sources: analyst consensus ratings from 2 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ELTX price target is $17.00 (+25.5% upside), with an analyst consensus of Buy.
The ELTX short-term stock prediction for tomorrow is $14.23 (+5.00%). The ELTX stock price prediction for 2027 estimates an average of $29. The ELTX stock prediction for 2030 projects a range of $61–$78.
Elicio Therapeutics, Inc. trades on NASDAQ under the ticker ELTX. The ELTX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 50% of covering analysts.
Frequently asked questions
ELTX forecast · 8 questionsAccording to 2 Wall Street analysts, the average 12-month ELTX price target is $17.00, with a high forecast of $17.00 and a low of $17.00. The median price target is shown in the chart above when available. This implies +25.5% potential upside from the current price of $13.55.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.